Načítá se...
Assessing the benefits and harms of low-dose computed tomography screening for lung cancer
The concept of using low-dose computed tomography (LDCT) for lung cancer screening goes back almost 25 years. In 2011, the National Lung Screening Trial (NLST) reported that LDCT screening significantly reduced mortality from lung cancer in a high risk population. This article evaluates the benefits...
Uloženo v:
| Vydáno v: | Lung Cancer Manag |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4662564/ https://ncbi.nlm.nih.gov/pubmed/26617677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/LMT.14.41 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|